These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19025790)

  • 1. Children's health risk assessment: incorporating a lifestage approach into the risk assessment process.
    Brown RC; Barone S; Kimmel CA
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):511-21. PubMed ID: 19025790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment.
    Makris SL; Thompson CM; Euling SY; Selevan SG; Sonawane B
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):530-46. PubMed ID: 19085945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lifestage approach to assessing children's exposure.
    Cohen Hubal EA; Moya J; Selevan SG
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):522-9. PubMed ID: 19025791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contrast between risk assessment and rules of evidence in the context of international trade disputes: can the US experience inform the process?
    Anderson EL; Hilaire CS
    Risk Anal; 2004 Apr; 24(2):449-59. PubMed ID: 15078316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policy and science in children's health and environment: recommendations from the PINCHE project.
    van den Hazel P; Zuurbier M; Bistrup ML; Busby C; Fucic A; Koppe JG; Lundqvist C; Ronchetti R; ten Tusscher G
    Acta Paediatr Suppl; 2006 Oct; 95(453):114-9. PubMed ID: 17000578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early lifestage exposure and potential developmental susceptibility to tetrachloroethylene.
    Brown Dzubow R; Makris S; Siegel Scott C; Barone S
    Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):50-65. PubMed ID: 20041493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycotoxins and child health: the need for health risk assessment.
    Sherif SO; Salama EE; Abdel-Wahhab MA
    Int J Hyg Environ Health; 2009 Jul; 212(4):347-68. PubMed ID: 18805056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment and child health.
    Samet JM
    Pediatrics; 2004 Apr; 113(4 Suppl):952-6. PubMed ID: 15060187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action as a determining factor in additivity models for chemical mixture risk assessment.
    Lambert JC; Lipscomb JC
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):183-94. PubMed ID: 17804132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confronting social disparities in child health: a critical appraisal of life-course science and research.
    Wise PH
    Pediatrics; 2009 Nov; 124 Suppl 3():S203-11. PubMed ID: 19861471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurses' role in children's environmental health protection.
    Sattler B; Davis del BA
    Pediatr Nurs; 2008; 34(4):329-39. PubMed ID: 18814568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the ERICA Integrated Approach to the assessment and management of environmental risks from ionising contaminants.
    Larsson CM
    J Environ Radioact; 2008 Sep; 99(9):1364-70. PubMed ID: 18261830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk assessment: present and future.
    Szymczak W; Szadkowska-Stańczyk I
    Int J Occup Med Environ Health; 2005; 18(3):207-23. PubMed ID: 16411559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health visitors' child protection work: exploratory study of risk assessment.
    Selbie J
    Community Pract; 2009 May; 82(5):28-31. PubMed ID: 19480117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment of chemicals and pharmaceuticals in the pediatric population: a workshop report.
    Pohl HR; van Engelen JG; Wilson J; Sips AJ
    Regul Toxicol Pharmacol; 2005 Jun; 42(1):83-95. PubMed ID: 15896447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the incorporation of chemical-specific information in risk assessment.
    Clewell HJ; Andersen ME; Blaauboer BJ
    Toxicol Lett; 2008 Aug; 180(2):100-9. PubMed ID: 18588959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is epidemiology the key to cumulative risk assessment?
    Levy JI
    Risk Anal; 2008 Dec; 28(6):1507-13. PubMed ID: 18793279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease risk analysis: a tool for primate conservation planning and decision making.
    Travis DA; Hungerford L; Engel GA; Jones-Engel L
    Am J Primatol; 2006 Sep; 68(9):855-67. PubMed ID: 16900501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental risk assessment of zinc in European freshwaters: a critical appraisal.
    Van Sprang PA; Verdonck FA; Van Assche F; Regoli L; De Schamphelaere KA
    Sci Total Environ; 2009 Oct; 407(20):5373-91. PubMed ID: 19631966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.